SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: sam who wrote (4629)6/30/1998 9:44:00 AM
From: Biomaven  Read Replies (4) | Respond to of 6136
 
There's a WSJ article plugging Sustiva today - suggests it might replace PI's. Makes a big deal of low pill count for Combivir + Sustiva (3 pills/day) compared to AZT+3TC+Crix (10 pills). Of course doesn't mention what Combivir+Viracept would be...

Looks to me like today is the day to buy AGPH.

Peter